Last Updated : July 29, 2025
Details
| Call for patient/clinician input open | May 10, 2024 |
|---|---|
| Call for patient/clinician input closed | July 08, 2024 |
| Submission received | June 21, 2024 |
| Submission accepted | July 08, 2024 |
| Review initiated | July 09, 2024 |
| Draft CADTH review report(s) provided to sponsor for comment | September 26, 2024 |
| Deadline for sponsors comments | October 08, 2024 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | November 15, 2024 |
| Expert committee meeting (initial) | November 27, 2024 |
| Draft recommendation issued to sponsor | December 09, 2024 |
| Draft recommendation posted for stakeholder feedback | December 19, 2024 |
| End of feedback period | January 10, 2025 |
| Clarification: - Reconsideration: major revisions requested by sponsor | |
| Expert committee meeting | March 26, 2025 |
| Final recommendation issued to sponsor and drug plans | April 08, 2025 |
| Final recommendation posted | April 28, 2025 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | April 24, 2025 |
| CDA-AMC review report(s) posted | July 29, 2025 |